Skip to main content
Clinical Trials/NCT04243070
NCT04243070TerminatedNot Applicable

Collection of ECG Signals From Various Patient Groups for the Development of Algorithms for Sensing and Detection of Rhythm Anomalies

Biotronik SE & Co. KG5 sites in 1 country89 target enrollmentStarted: March 10, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
89
Locations
5
Primary Endpoint
Number of Successful ECG Recordings Per Condition

Study Overview

Brief Summary

Collection of Holter surface ECGs for the development of new sensing and detection algorithms

Detailed Description

The aim of the study is to collect data from surface ECGs by using Holter ECG recordings from patients with different forms of diagnosed arrhythmias and/or specific ECG characteristics from heart diseases to support the development of new sensing and detection algorithms for implants.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patient is able to understand the nature of the study and willing to provide written informed consent.
  • •Patient is willing and able to attend Holter ECG procedure following a visit
  • •History of at least one of the following conditions (established via ECG prior to enrollment):
  • •(A) Patient with pacemaker/ICD and
  • •Ventricular stimulation > 30 % or
  • •(B) Patient either without pacemaker/ICD or with pacemaker/ICD, but without significant atrial and ventricular stimulation and at least one of the following:
  • •Frequent Ventricular Extrasystoles (VES) (incl. Bigeminus) or
  • •Atrioventricular Reentrant Tachycardia (AVRT)/Wolff-Parkinson-White (WPW) syndrome or
  • •Atrioventricular Nodal Reentrant Tachycardia (AVNRT) or
  • •Sinus Tachycardia at rest or
  • •Atrial Flutter or
  • •Any form of Ventricular Tachycardia (VT) or
  • •Silent/Paroxysmal/persistent/permanent AF or
  • •Brugada syndrome or
  • •Long QT syndrome or
  • •Right Bundle Branch Block (RBBB) or
  • •Left Bundle Branch Block (LBBB) or
  • •Myocardial Ischemia/Acute Myocardial Infarction or
  • •Other abnormal QRS(T) complex, ST segment or T-wave morphology, i.e. any other QRS anomaly / ST segment elevation / ST segment Depression / T wave changes

Exclusion Criteria

  • •Any condition which precludes the patient's ability to comply with the study requirements.
  • •Known allergy to patch electrodes.
  • •Pregnant or breast feeding.
  • •Less than 18 years old.
  • •Participation in another interventional clinical investigation

Arms & Interventions

3-channel Holter ECG recording for EPS patient

Other

Patients participating in an EPS will undergo a 3-channel Holter ECG recording in parallel to the standard 12-channel Holter ECG recording during the EPS followed by an optional 24 h observation period

Intervention: 3-channel Holter ECG recording (Diagnostic Test)

12-channel Holter ECG recording for non-EPS patients

Other

Patients scheduled for a follow-up for their heart disease will undergo a 12-channel Holter ECG recording while participating in a Body Motion test followed by a 24 h observation period

Intervention: 12-channel Holter ECG recording (Diagnostic Test)

Outcomes

Primary Outcomes

Number of Successful ECG Recordings Per Condition

Time Frame: 24 hours

All ECG recordings were evaluated by an internal board and all patients were allocated to one of 15 groups (covering 14 ECG patterns of interest and one group for "no ECG pattern of interest recorded").

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (5)

Loading locations...

Similar Trials